Loading...

We've got a brand new version of Simply Wall St! Try it out

FinCanna Capital

DB:4AL
Snowflake Description

High growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
4AL
DB
CA$10M
Market Cap
  1. Home
  2. DE
  3. Diversified Financials
Company description

FinCanna Capital Corp. operates as a royalty investment company for the licensed medical cannabis industry in the United States. The last earnings update was 15 days ago. More info.


Add to Portfolio Compare Print
  • FinCanna Capital has significant price volatility in the past 3 months.
4AL Share Price and Events
7 Day Returns
-21.4%
DB:4AL
5%
DE Diversified Financial
2.5%
DE Market
1 Year Returns
-58.2%
DB:4AL
1.4%
DE Diversified Financial
2.6%
DE Market
4AL Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
FinCanna Capital (4AL) -21.4% -4.2% -14.4% -58.2% - -
DE Diversified Financial 5% 7% -5% 1.4% 75.8% 333.8%
DE Market 2.5% 0.2% 1% 2.6% 7.8% 23.7%
1 Year Return vs Industry and Market
  • 4AL underperformed the Diversified Financial industry which returned 1.4% over the past year.
  • 4AL underperformed the Market in Germany which returned 2.6% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

4AL Value

 Is FinCanna Capital undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for FinCanna Capital. This is due to cash flow or dividend data being unavailable. The share price is €0.0728.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for FinCanna Capital's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are FinCanna Capital's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:4AL PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-07-31) in CAD CA$0.00
CNSX:CALI Share Price ** CNSX (2019-10-11) in CAD CA$0.1
Germany Diversified Financial Industry PE Ratio Median Figure of 6 Publicly-Listed Diversified Financial Companies 27.82x
Germany Market PE Ratio Median Figure of 417 Publicly-Listed Companies 19.72x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of FinCanna Capital.

DB:4AL PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:CALI Share Price ÷ EPS (both in CAD)

= 0.1 ÷ 0.00

54.59x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • FinCanna Capital is overvalued based on earnings compared to the DE Diversified Financial industry average.
  • FinCanna Capital is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does FinCanna Capital's expected growth come at a high price?
Raw Data
DB:4AL PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 54.59x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
101.2%per year
Europe Diversified Financial Industry PEG Ratio Median Figure of 13 Publicly-Listed Diversified Financial Companies 1.81x
Germany Market PEG Ratio Median Figure of 264 Publicly-Listed Companies 1.38x

*Line of best fit is calculated by linear regression .

DB:4AL PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 54.59x ÷ 101.2%

0.54x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • FinCanna Capital is good value based on expected growth next year.
Price based on value of assets
What value do investors place on FinCanna Capital's assets?
Raw Data
DB:4AL PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-07-31) in CAD CA$0.19
CNSX:CALI Share Price * CNSX (2019-10-11) in CAD CA$0.1
Germany Diversified Financial Industry PB Ratio Median Figure of 9 Publicly-Listed Diversified Financial Companies 3.77x
Germany Market PB Ratio Median Figure of 597 Publicly-Listed Companies 1.74x
DB:4AL PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:CALI Share Price ÷ Book Value per Share (both in CAD)

= 0.1 ÷ 0.19

0.52x

* Primary Listing of FinCanna Capital.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • FinCanna Capital is good value based on assets compared to the DE Diversified Financial industry average.
X
Value checks
We assess FinCanna Capital's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Diversified Financial industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Diversified Financial industry average (and greater than 0)? (1 check)
  5. FinCanna Capital has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

4AL Future Performance

 How is FinCanna Capital expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
101.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is FinCanna Capital expected to grow at an attractive rate?
  • FinCanna Capital's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • FinCanna Capital's earnings growth is expected to exceed the Germany market average.
  • FinCanna Capital's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:4AL Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:4AL Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 101.2%
DB:4AL Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 62.8%
Germany Diversified Financial Industry Earnings Growth Rate Market Cap Weighted Average 17.3%
Europe Diversified Financial Industry Revenue Growth Rate Market Cap Weighted Average 0.6%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:4AL Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:4AL Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-04-30 12 5 1
2021-04-30 7 2 1
2020-04-30 4 0 0 1
2019-10-12
DB:4AL Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-07-31 1 -2 0
2019-04-30 1 -3 0
2019-01-31 2 -1 0
2018-10-31 2 -5 -10
2018-07-31 1 -5 -12
2018-04-30 1 -4 -13
2017-04-30 0 -1 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • FinCanna Capital's earnings are expected to grow significantly at over 20% yearly.
  • FinCanna Capital's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:4AL Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from FinCanna Capital Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:4AL Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-04-30 0.04 0.04 0.04 1.00
2021-04-30 0.01 0.01 0.01 1.00
2020-04-30 0.00 0.00 0.00 1.00
2019-10-12
DB:4AL Past Financials Data
Date (Data in CAD Millions) EPS *
2019-07-31 0.00
2019-04-30 0.00
2019-01-31 0.00
2018-10-31 -0.13
2018-07-31 -0.20
2018-04-30 -0.31
2017-04-30 -0.13

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if FinCanna Capital will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess FinCanna Capital's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
FinCanna Capital has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

4AL Past Performance

  How has FinCanna Capital performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare FinCanna Capital's growth in the last year to its industry (Diversified Financial).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Insufficient data to establish if FinCanna Capital's year on year earnings growth rate was positive over the past 5 years.
  • FinCanna Capital has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • FinCanna Capital has become profitable in the last year making it difficult to compare the Europe Diversified Financial industry average.
Earnings and Revenue History
FinCanna Capital's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from FinCanna Capital Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:4AL Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-07-31 1.18 0.18 2.87
2019-04-30 1.49 0.21 3.51
2019-01-31 1.74 0.11 3.59
2018-10-31 2.11 -9.67 5.67
2018-07-31 1.23 -11.56 5.49
2018-04-30 0.84 -12.70 5.48
2017-04-30 -0.01 -1.26 0.80

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • FinCanna Capital has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • FinCanna Capital used its assets less efficiently than the DE Diversified Financial industry average last year based on Return on Assets.
  • Unable to establish if FinCanna Capital improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.
X
Past performance checks
We assess FinCanna Capital's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Diversified Financial industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
FinCanna Capital has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

4AL Health

 How is FinCanna Capital's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up FinCanna Capital's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • FinCanna Capital is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • FinCanna Capital's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of FinCanna Capital's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 3.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from FinCanna Capital Company Filings, last reported 2 months ago.

DB:4AL Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-07-31 19.15 4.33 5.85
2019-04-30 19.77 4.27 7.83
2019-01-31 19.75 2.14 2.76
2018-10-31 19.84 0.00 2.57
2018-07-31 18.23 0.00 5.68
2018-04-30 12.73 0.00 2.72
2017-04-30 1.31 0.00 0.03
  • FinCanna Capital's level of debt (22.6%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if FinCanna Capital's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on FinCanna Capital's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess FinCanna Capital's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. FinCanna Capital has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

4AL Dividends

 What is FinCanna Capital's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from FinCanna Capital dividends.
If you bought €2,000 of FinCanna Capital shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate FinCanna Capital's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate FinCanna Capital's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:4AL Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Europe Diversified Financial Industry Average Dividend Yield Market Cap Weighted Average of 32 Stocks 3.2%
Germany Market Average Dividend Yield Market Cap Weighted Average of 337 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:4AL Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2022-04-30
2021-04-30
2020-04-30
2019-10-12

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as FinCanna Capital has not reported any payouts.
  • Unable to verify if FinCanna Capital's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of FinCanna Capital's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as FinCanna Capital has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess FinCanna Capital's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can FinCanna Capital afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. FinCanna Capital has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

4AL Management

 What is the CEO of FinCanna Capital's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Andriyko Herchak
AGE 47
TENURE AS CEO 2.5 years
CEO Bio

Mr. Andriyko Taras Herchak, CPA, CA, B. Com., is Chief Executive Officer of FinCanna Capital Corp. since April 2017 and its Director since April 20, 2017. Mr. Herchak served as President at FinCanna Capital Corp. until June 2019. Mr. Herchak has been a Director of Sixty North Gold Mining Ltd. since July 24, 2017. He has more than 20 years of executive leadership experience with publicly traded companies. He served as Chief Financial Officer of FinCanna Capital Corp. from February 2017 to March 2017. He served as the Chief Financial Officer of Hathor Exploration Ltd. since July 1, 2007 until February 2012. He served as the Chief Financial Officer at NexGen Energy Ltd. since May 29, 2013 until November 21, 2014. Mr. Herchak served as Chief Financial Officer and President of Southern Energy Corp. (formerly, Standard Exploration Ltd.) from April 2009 to September 13, 2010. He served as the Chief Financial Officer of Playground, a division of Intrawest Corporation. Mr. Herchak served senior financial positions at several publicly listed companies, including six years at Intrawest Corporation and FACS Records Income Trust. He has been a Director of Navasota Resources Ltd., since July 2008. He served as a Director of Guyana Frontier Mining Corp. (alternate name: Shoreham Resources Ltd.) until December 2008. He served as a Director of Anglo Aluminum Corp from July 2008 to August 2012. He received his designation as a Chartered Accountant in 1995 while articling with the international accounting firm of Deloitte & Touche in Vancouver. He graduated with a Bachelors of Commerce degree from the University of British Columbia. He was the Chief Financial Officer of the Sixty North Gold Mining Ltd. from February 2017 to March 2017. Mr. Herchak served as the Chief Financial Officer of Jewel Holdings Ltd. from June 2015 to April 2017.

CEO Compensation
  • Insufficient data for Andriyko to compare compensation growth.
  • Insufficient data for Andriyko to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team

Andriyko Herchak

TITLE
CEO & Director
AGE
47
TENURE
2.5 yrs

Rob Scott

TITLE
CFO & Director
AGE
49

Jeff Dare

TITLE
Corporate Secretary & Director
AGE
39
Board of Directors Tenure

Average tenure and age of the FinCanna Capital board of directors in years:

1.2
Average Tenure
48.5
Average Age
  • The average tenure for the FinCanna Capital board of directors is less than 3 years, this suggests a new board.
Board of Directors

Morris Reid

TITLE
Chairman of the Board
TENURE
0.5 yrs

Andriyko Herchak

TITLE
CEO & Director
AGE
47
TENURE
2.5 yrs

Rob Scott

TITLE
CFO & Director
AGE
49
TENURE
2.4 yrs

Jeff Dare

TITLE
Corporate Secretary & Director
AGE
39
TENURE
2.4 yrs

Jeff Tindale

TITLE
Member of Board of Advisors
AGE
48
TENURE
1.2 yrs

Gaynell Rogers

TITLE
Advisor to the Board of Directors

Norman Campbell

TITLE
Member of Advisory Board
AGE
65
TENURE
1.3 yrs

Robert Kamm

TITLE
Director
TENURE
1.2 yrs

Rosy Mondin

TITLE
Member of Board of Advisors
AGE
50
TENURE
1.1 yrs

Dani Walton

TITLE
Member of Advisory Board
TENURE
0.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
21. Dec 18 Buy Robert Scott Individual 21. Dec 18 21. Dec 18 100,000 €0.05 €5,494
06. Dec 18 Buy Robert Scott Individual 05. Dec 18 05. Dec 18 50,000 €0.09 €4,179
29. Nov 18 Buy Andriyko Herchak Individual 28. Nov 18 28. Nov 18 35,000 €0.10 €3,605
21. Nov 18 Buy Andriyko Herchak Individual 20. Nov 18 20. Nov 18 15,000 €0.10 €1,540
01. Nov 18 Buy Robert Scott Individual 29. Oct 18 29. Oct 18 68,000 €0.12 €7,783
29. Oct 18 Buy Andriyko Herchak Individual 29. Oct 18 29. Oct 18 50,000 €0.11 €5,521
X
Management checks
We assess FinCanna Capital's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. FinCanna Capital has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

4AL News

Simply Wall St News

4AL Company Info

Description

FinCanna Capital Corp. operates as a royalty investment company for the licensed medical cannabis industry in the United States. It provides financing for companies operating in the medical cannabis sector in exchange for a royalty on revenues. The company has royalty agreements with Cultivation Technologies Inc.; Green Compliance Inc.; QVI, Inc.; and Refined Resin Technologies Inc. FinCanna Capital Corp. is headquartered in Vancouver, Canada.

Details
Name: FinCanna Capital Corp.
4AL
Exchange: DB
Founded:
CA$6,821,731
99,289,734
Website: http://www.fincannacapital.com
Address: FinCanna Capital Corp.
800 West Pender Street,
Suite 550,
Vancouver,
British Columbia, V6C 2V6,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX CALI Common Shares Canadian National Stock Exchange CA CAD 29. Dec 2017
OTCPK FNNZ.F Common Shares Pink Sheets LLC US USD 29. Dec 2017
DB 4AL Common Shares Deutsche Boerse AG DE EUR 29. Dec 2017
Number of employees
Current staff
Staff numbers
0
FinCanna Capital employees.
Industry
Specialized Finance
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/10/12 23:25
End of day share price update: 2019/10/11 00:00
Last estimates confirmation: 2019/08/28
Last earnings filing: 2019/09/27
Last earnings reported: 2019/07/31
Last annual earnings reported: 2019/04/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.